AMIX · Autonomix Medical, Inc. · Executive Compensation
$3.68
-0.10 (-2.65%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued. The accompanying condensed financial statements have been prepared on a going concern basis and do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.72M
Shares
971,043
Volume · Oct 2
2.58M
Avg daily vol (3M)
4.5M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sandra Kalter | independent member of the Company's Board | Appointed | 2026-09-16 |
| Lori Bisson | Executive Vice Chair and Strategic Adviser to the Chief Executive Officer | Appointed | 2024-06-17 |
| Brad Hauser | chief executive officer and president | Appointed | 2024-06-17 |